New Antibody Shows Promise for Preventing RSV in Infants

Thanks to a collaboration between the pharmaceutical company MedImmune and Geisel structural biologist Jason McLellan, PhD, a long-awaited vaccine to protect infants from RSV may soon become a reality. Their findings are featured as this month’s cover story in the journal Science Translational Medicine.
Source: News at Dartmouth Medical School - Category: Hospital Management Authors: Tags: News Features Jason McLellan pediatrics research RSV virus Source Type: news